Journal Publications:
12. Rubio, A., Baharani, V., Dadonaite, B., Parada, M., Abernathy, M.E., Wang, Z., Lee, Y., Eso, M., Phung, J., Ramos, I., Chen, T., El Nesr, G., Bloom, J., Bieniasz, P., Nussenzweig, M., Barnes, C.O. Bispecific antibodies targeting the N-terminal and receptor binding domains potently neutralize SARS-CoV-2 variants of concern. Science Translational Medicine, 17, eadq5720 (2025).
11. Zhang, F., Jenkins, J., de Carvalho, R.V.H., Nakandakari-Higa, S., Chen, T., Abernathy, M.E., Baharani, V.A., Nyakatura, E.K., Andrew, D., Lebedeva, I.V., Lorenz, I.C., Hoffmann, H.H., Rice, C.M., Victora, G.D., Barnes, C.O., Hatziioannou, T., Bieniasz, P.D. Pan-sarbecovirus prophylaxis with human anti-ACE2 monoclonal antibodies. Nature Microbiology, 8, 1051-1063 (2023).
10. Bianchini, F.*, Crivelli, V.*, Abernathy, M.E.*, Guerra, C.*, Palus, M.*, Muri, J., Marcotte, H., Piralla, A., Pedotti, M., De Gasparo, R., Simonelli, L., Matkovic, M., Toscano, C., Biggiogero, M., Calvaruso, V., Svoboda, P., Cervantes Rincón, T., Fava, T., Podešvová, L., Shanbhag, A.A., Celoria, A., Sgrignani, J., Stefanik, M., Hönig, V., Pranclova, V., Michalcikova, T., Prochazka, J., Guerrini, G., Mehn, D., Ciabattini, A., Abolhassani, H., Jarrossay, D., Uguccioni, M., Medaglini, D., Pan-Hammarström, Q., Calzolai, L., Fernandez, D., Baldanti, F., Franzetti-Pellanda, A., Garzoni, C., Sedlacek, R., Ruzek, D., Varani, L., Cavalli, A., Barnes, C.O., Robbiani, D.F. Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein. Science Immunology, 8, eade0958 (2023).
9. Gristick, H.B.*, Hartweger, H.*, Loewe, M., van Schooten, J., Ramos, V., Oliviera, T.Y., Nishimura, Y., Koranda, N.S., Wall, A., Yao, K-H., Poston, D., Gazumyan, A., Wiatr, M., Horning, M., Keeffe, J.R., Hoffmann, M.A.G., Yang, Z., Abernathy, M.E., Dam, K.A., Gao, H., Gnanapragasam, P.N.P., Kakutani, L.M., Pavlovitch-Bedzyk, A.J., Seaman, M.S., Howarth, M., McGuire, A.T., Stamatatos, L., Martin, M.A., West, A.P., Nussenzweig, M.C., Bjorkman, P.J. CD4 binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wild-type animals. Science Immunology, 8, eade6364 (2023).
8. Escolano, A.*, Gristick, H.B.*, Gautam, R.*, DeLaitsch, A.T.*, Abernathy, M.E., Yang, Z., Wang, H., Hoffmann, M.A.G., Nishimura, Y., Wang, Z., Koranda, N., Kakutani, L.M., Gao, H., Gnanapragasam, P.N.P., Raina, H., Gazumyan, A., Cipolla, M., Oliveria, T.Y., Ramos, V., Irvine, D.J., Silva, M., West, A.P., Keeffe, J.R., Barnes, C.O., Seaman, M.S., Nussenzweig, M.C., Martin, M.A., Bjorkman, P.J. Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env. Science Translational Medicine, 13, eabk1533 (2021).
7. Abernathy, M.E., Gristick, H.B, Vielmetter, J., Keeffe, J.R., Gnanapragasam, P.N.P, Lee, Y.E., Escolano, A., Gautam, R., Seaman, M.S., Martin, M.A., Nussenzweig, M.C., Bjorkman, P.J. Antibody elicited by HIV-1 immunogen vaccination in macaques displaces Env fusion peptide and destroys a neutralizing epitope. npj Vaccines, 6, 126 (2021).
6. Abernathy, M.E.*, Dam, K.A.*, Esswein, S.R.*, Jette, C.A.*, Bjorkman, P.J. How Antibodies Recognize Pathogenic Viruses: Structural Correlates of Antibody Neutralization of HIV-1, SARS-CoV-2, and Zika. Viruses, 13, 2106 (2021).
5. , , F., , , , C.O., , S.,, , M., , C., , J.A., , Z., , M.E., ,, A.,, M., , K.A., ,, K.G., , V.,, J., , J., , R.A.,, R.,, J., , C., , I.,, , M., , , R.,, T., , P.D.,. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature, 592, 616–622 (2021).
4. Barnes, C.O., Jette, C.A., Abernathy, M.E., Dam, K-M.A., Esswein, S.R., Gristick, H.B., Malyutin, A.G., Sharaf, N.G., Huey-Tubman, K.E., Lee, Y.E., Robbiani, D.F., Nussenzweig, M.C., West, A.P., Bjorkman, P.J. SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature, 588, 682–687 (2020).
3. Schommers, P.*, Gruell, H.*, Abernathy, M.E.*, Tran, M-K., Dingens, A.S., Gristick, H.B., Barnes, C.O., Schoofs, T., Schlotz, M., Vanshylla, K., Kreer, C., Weiland, D., Holtick, U., Scheid, C., Valter, M.M, van Gils, M.J., Sanders, R.W., Vehreschild, J.J., Cornely, O.A., Lehmann, C., Fatkenheuer, G., Seaman, M.S., Bloom, J.D., Bjorkman, P.J., and Klein, F. Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody. Cell, 180, 1-19 (2020).
2. Escolano, A., Gristick, H.B., Abernathy, M.E., Merkenschlager, J., Gautam, R., Oliveira, T.Y., Pai, J., West, A.P., Barnes, C.O., Cohen, A.A., Wang, H., Golijanin, J., Yost, D., Keeffe, J.R., Wang, Z., Zhao, P., Yao, K-H., Bauer, J., Nogueira, L., Gao, H., Voll, A.V., Montefiori, D.C., Seaman, M.S., Gazumyan, A., Silva, M., McGuire, A.T., Stamatatos, L., Irvine, D.J., Wells, L., Martin, M.A., Bjorkman, P.J., Nussenzweig, M.C. Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques. Nature, 570, 468-473 (2019).
1. Ohata, J., Minus, M.B., Abernathy, M.E., Ball, Z.T. Histidine-Directed Arylation/Alkenylation of Backbone N–H Bonds Mediated by Copper(II). J. Am. Chem. Soc., 138, 7472–7475 (2016).
*Equal contributions
Morgan Abernathy 